The results of two phase 3 trials investigating Survodutide, a weight loss drug from Boehringer Ingelheim, suggest that the ...

Participants were free to decide whether they wished to maintain their weight or pursue further weight loss. The majority opted for additional weight reduction following the initial 16‑week period.

MALAGA, Spain—Patients with obesity treated with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy; Novo Nordisk) can achieve weight loss in the real world similar to what has ...

A recent study was conducted by Pakhale and colleagues to determine whether weight reduction by dieting could ameliorate airway hyperresponsiveness (AHR), a characteristic and quantifiable feature of ...

Closeup of a person standing barefoot on the beach. This article explains when Medicare might cover weight loss programs. It also looks at what weight loss services Medicare covers. BMI is a ...

Credit: Getty Images By reinforcing the essential role of exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and improves functional health.

New research presented at this year’s European Congress on Obesity (ECO 2026) in Istanbul, Turkey, shows that rapid weight ...

Share on Pinterest Weight loss drugs may offer added heart-health benefits, such as reducing blood pressure levels. Image credit: Design by MNT; Photography by Tatiana Maksimova/Getty Images A ...